NCT01562080View on ClinicalTrials.gov

Combined Effects of Bioactive Compounds in Lipid Profile

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
HyperlipidemiaLow-density-lipoprotein-typeElevated Triglycerides
Interventions
DIETARY_SUPPLEMENT

Armolipid Plus

one tablet per day during 12 weeks

DIETARY_SUPPLEMENT

placebo

one tablet per day during 12 weeks

Trial Locations (1)

Unknown

Hosp. Universitario San Joan, Reus

All Listed Sponsors
collaborator

Centro Tecnológico de Nutrición y Salud

OTHER

lead

Rottapharm Spain

INDUSTRY

NCT01562080 - Combined Effects of Bioactive Compounds in Lipid Profile | Biotech Hunter | Biotech Hunter